Advisor Group Holdings, Inc. X Biotech Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.22 - $4.72 $966 - $1,416	-300 Reduced 85.71%	50 $0
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $1,074 - $1,764	300 Added 600.0%	350 $1,000
Q1 2022 May 04, 2022	BUY	$8.64 - $11.71 $432 - $585	50 New	50 $0
Q1 2021 May 13, 2021	SELL	$15.92 - $20.3 $4,776 - $6,090	-300 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$15.65 - $19.92 $1,565 - $1,992	-100 Reduced 25.0%	300 $5,000
Q3 2020 Nov 12, 2020	BUY	$13.97 - $21.16 $1,397 - $2,116	100 Added 33.33%	400 $8,000
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $3,117 - $4,821	300 New	300 $4,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.